-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
-
The benefit of regular follow-up for monoclonal gammopathy of unknown significance (MGUS) to detect progression to multiple myeloma (MM) remains unknown.
-
Drugs in the statin class have clearly demonstrated clinical benefit, particularly in lowering cholesterol and reducing cardiovascular mortality.
-
Extensive literature is developing on the role of functional assessment of cancer patients, particularly those who are elderly, in order to provide safer and more effective treatment.
-
A 64-year-old man was referred because of leukocytosis. He had been in his usual state of health until approximately two months prior to a visit, when he was diagnosed by his primary care provider with pneumonia.
-
-
Hospitals and provider networks lead the list of health care entities reporting breaches of unsecured protected health information (PHI), according to the Office for Civil Rights (OCR) breach notification website, which lists 166 entities as of Sept. 30.
-
Four months in prison and a $2,000 fine to Huping Zhou, a 47-year-old cardiothoracic surgeon from China and a UCLA health care system employee, for violating the Health Insurance Portability and Accountability Act (HIPAA) should be a cause for concern for hospitals.
-
Although business associates are now subject to compliance with the HIPAA Security Rule and the use and disclosure provisions of the HIPAA Privacy Rule, as a result of the Health Information Technology for Economic and Clinical Health (HITECH) Act, hospitals should not assume business associates are taking steps to ensure their compliance.